These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 31539218)

  • 1. Treatment of Localized Aggressive Periodontitis With Guided Tissue Regeneration Technique and Enamel Matrix Derivative.
    Momen-Heravi F; Kang P
    Clin Adv Periodontics; 2017 Nov; 7(4):182-189. PubMed ID: 31539218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical outcomes following regenerative therapy of non-contained intrabony defects using a deproteinized bovine bone mineral combined with either enamel matrix derivative or collagen membrane.
    Iorio-Siciliano V; Andreuccetti G; Blasi A; Matarasso M; Sculean A; Salvi GE
    J Periodontol; 2014 Oct; 85(10):1342-50. PubMed ID: 24835417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of intrabony defects using guided tissue regeneration or enamel matrix derivative: a 3-year prospective randomized clinical study.
    Crea A; Dassatti L; Hoffmann O; Zafiropoulos GG; Deli G
    J Periodontol; 2008 Dec; 79(12):2281-9. PubMed ID: 19053918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of enamel matrix derivative in the treatment of periodontal defects: a literature review and meta-analysis.
    Venezia E; Goldstein M; Boyan BD; Schwartz Z
    Crit Rev Oral Biol Med; 2004 Nov; 15(6):382-402. PubMed ID: 15574680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deproteinized bovine bone in association with guided tissue regeneration or enamel matrix derivatives procedures in aggressive periodontitis patients: a 1-year retrospective study.
    Artzi Z; Tal H; Platner O; Wasersprung N; Weinberg E; Slutzkey S; Gozali N; Carmeli G; Herzberg R; Kozlovsky A
    J Clin Periodontol; 2015 Jun; 42(6):547-56. PubMed ID: 25950086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of intrabony defects with anorganic bone matrix/p-15 or guided tissue regeneration in patients with aggressive periodontitis.
    Queiroz AC; Nóbrega PB; Oliveira FS; Novaes AB; Taba M; Palioto DB; Grisi MF; Souza SL
    Braz Dent J; 2013; 24(3):204-12. PubMed ID: 23969907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Three-year results following regenerative periodontal surgery of advanced intrabony defects with enamel matrix derivative alone or combined with a synthetic bone graft.
    Hoffmann T; Al-Machot E; Meyle J; Jervøe-Storm PM; Jepsen S
    Clin Oral Investig; 2016 Mar; 20(2):357-64. PubMed ID: 26174080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical outcomes after treatment of non-contained intrabony defects with enamel matrix derivative or guided tissue regeneration: a 12-month randomized controlled clinical trial.
    Siciliano VI; Andreuccetti G; Siciliano AI; Blasi A; Sculean A; Salvi GE
    J Periodontol; 2011 Jan; 82(1):62-71. PubMed ID: 20809859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Periodontal regeneration - intrabony defects: a consensus report from the AAP Regeneration Workshop.
    Reynolds MA; Kao RT; Camargo PM; Caton JG; Clem DS; Fiorellini JP; Geisinger ML; Mills MP; Nares S; Nevins ML
    J Periodontol; 2015 Feb; 86(2 Suppl):S105-7. PubMed ID: 25315019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Periodontal regeneration with a combination of enamel matrix proteins and autogenous bone grafting.
    Cochran DL; Jones A; Heijl L; Mellonig JT; Schoolfield J; King GN
    J Periodontol; 2003 Sep; 74(9):1269-81. PubMed ID: 14584859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Five-year clinical results for treatment of intrabony defects with EMD, guided tissue regeneration and open-flap debridement: a case series.
    Mitani A; Takasu H; Horibe T; Furuta H; Nagasaka T; Aino M; Fukuda M; Fujimura T; Mogi M; Noguchi T
    J Periodontal Res; 2015 Feb; 50(1):123-30. PubMed ID: 24815103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Healing of human intrabony defects following treatment with enamel matrix proteins or guided tissue regeneration.
    Sculean A; Donos N; Windisch P; Brecx M; Gera I; Reich E; Karring T
    J Periodontal Res; 1999 Aug; 34(6):310-22. PubMed ID: 10633886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical evaluation of demineralized freeze-dried bone allograft and enamel matrix derivative versus enamel matrix derivative alone for the treatment of periodontal osseous defects in humans.
    Gurinsky BS; Mills MP; Mellonig JT
    J Periodontol; 2004 Oct; 75(10):1309-18. PubMed ID: 15562907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of clinical, radiographic, and histometric measurements following treatment with guided tissue regeneration or enamel matrix proteins in human periodontal defects.
    Windisch P; Sculean A; Klein F; Tóth V; Gera I; Reich E; Eickholz P
    J Periodontol; 2002 Apr; 73(4):409-17. PubMed ID: 11990442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two-year follow-up of treatment of intrabony periodontal defect with enamel matrix derivative.
    Fujinami K; Hayakawa H; Ota K; Ida A; Nikaido M; Makiishi T; Saito A
    Bull Tokyo Dent Coll; 2011; 52(4):215-21. PubMed ID: 22293592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioabsorbable membrane and bioactive glass in the treatment of intrabony defects in patients with generalized aggressive periodontitis: results of a 5-year clinical and radiological study.
    Mengel R; Schreiber D; Flores-de-Jacoby L
    J Periodontol; 2006 Oct; 77(10):1781-7. PubMed ID: 17032123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel flapless approach versus minimally invasive surgery in periodontal regeneration with enamel matrix derivative proteins: a 24-month randomized controlled clinical trial.
    Aimetti M; Ferrarotti F; Mariani GM; Romano F
    Clin Oral Investig; 2017 Jan; 21(1):327-337. PubMed ID: 27044318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Periodontal Regeneration with Enamel Matrix Derivative in the Management of Generalized Aggressive Periodontitis: A Case Report with 11-Year Follow-up and Literature Review.
    Trikka D; Vassilopoulos S
    J Int Soc Prev Community Dent; 2019; 9(1):13-20. PubMed ID: 30923688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A clinical comparison of a bovine-derived xenograft used alone and in combination with enamel matrix derivative for the treatment of periodontal osseous defects in humans.
    Scheyer ET; Velasquez-Plata D; Brunsvold MA; Lasho DJ; Mellonig JT
    J Periodontol; 2002 Apr; 73(4):423-32. PubMed ID: 11990444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and histologic evaluation of an enamel matrix derivative combined with a biphasic calcium phosphate for the treatment of human intrabony periodontal defects.
    Sculean A; Windisch P; Szendröi-Kiss D; Horváth A; Rosta P; Becker J; Gera I; Schwarz F
    J Periodontol; 2008 Oct; 79(10):1991-9. PubMed ID: 18834256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.